Navigation Links
Medivation Announces Pricing of Public Offering
Date:5/27/2009

SAN FRANCISCO, May 27 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced the pricing of its public offering of 2,750,000 shares of its common stock at a public offering price of $21.00 per share. The company expects to complete the sale of these shares on or about June 2, 2009. The company has granted the underwriters a 30-day option to purchase 412,500 additional shares of common stock to cover over-allotments, if any.

J.P. Morgan Securities Inc. is acting as sole book-running manager of the offering.

The company currently expects to use the net proceeds of this offering for general corporate purposes, including to support further research, development and commercialization of its product candidates, including its lead product candidate, Dimebon, and its product candidate MDV3100.

The offering is being made pursuant to a shelf registration statement filed with the Securities and Exchange Commission on August 3, 2007, that has been declared effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Copies of the prospectus supplement and related prospectus relating to the offering may be obtained from J.P. Morgan's prospectus department at 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245, Attention Prospectus Department (telephone number 718-242-8002).

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there ar
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009
2. Medivation Announces Upcoming Scientific Presentations at Medical Conferences
3. Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
4. Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
5. Medivation Presents New Data on Dimebons Novel Mechanism of Action
6. Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference
7. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
8. Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
9. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
10. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
11. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... are intensively investigated for application as catalysts, ... and components in photonics and molecular electronics. ... for understanding physical and chemical properties, has ... USA, have demonstrated that high-resolution electron microscopy ... structure in which all gold atoms are ...
(Date:8/22/2014)... 22, 2014 The AMA is pleased ... members in Alaska that Alaska Governor Sean Parnell has ... further defining public use of Unmanned Aircraft Systems and ... House Bill 255states that it is, “An Act relating ... by an unmanned aircraft system.” It defines State of ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 DNA vaccine ... progress in its development of JRC-LAMP-vax, an innovative and ... pollen. Phase IC studies began this month in Hawaii, ... hay fever. , The Japanese red cedar releases pollen ... in Japan. Mountain Cedar pollen wreaks similar havoc in ...
(Date:8/21/2014)... August 21, 2014 His Majesty Willem-Alexander, ... , The Court of His Majesty Willem-Alexander, King of ... the Grand Opening of POET-DSM Advanced Biofuels’ Project LIBERTY ... 3. , The King will take part in the ... scheduled for 11 a.m.-12:20 p.m. and tour the plant. ...
Breaking Biology Technology:A breakthrough in imaging gold nanoparticles to atomic resolution by electron microscopy 2State of Alaska Signs Unmanned Aircraft Systems Bill 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3
... Anacor Pharmaceuticals,announced today that it will ... and AN2898, at the upcoming,International Investigative Dermatology ... Kyoto, Japan. The IID Conference is the ... Dermatological Research (ESDR), the Japanese,Society for Investigative ...
... Limited (NYSE: MR ), a leading developer, manufacturer ... growing international,presence, today announced its selected unaudited financial results ... Highlights for First Quarter 2008 -- First quarter ... an increase of 48.2% over from ...
... Webcast and Conference Call Scheduled for Tuesday, May 13th at ... Therapeutics, Inc.,(Nasdaq: IMRX ) today announced that the Company ... 13, 2008, at 5:00 p.m. ET to discuss,first quarter 2008 ... ImaRx,s corporate website at, http://www.imarx.com and will be archived ...
Cached Biology Technology:Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference 2Mindray Medical International Announces First Quarter 2008 Results 2Mindray Medical International Announces First Quarter 2008 Results 3Mindray Medical International Announces First Quarter 2008 Results 4Mindray Medical International Announces First Quarter 2008 Results 5Mindray Medical International Announces First Quarter 2008 Results 6Mindray Medical International Announces First Quarter 2008 Results 7Mindray Medical International Announces First Quarter 2008 Results 8Mindray Medical International Announces First Quarter 2008 Results 9Mindray Medical International Announces First Quarter 2008 Results 10Mindray Medical International Announces First Quarter 2008 Results 11Mindray Medical International Announces First Quarter 2008 Results 12Mindray Medical International Announces First Quarter 2008 Results 13Mindray Medical International Announces First Quarter 2008 Results 14Mindray Medical International Announces First Quarter 2008 Results 15Mindray Medical International Announces First Quarter 2008 Results 16Mindray Medical International Announces First Quarter 2008 Results 17Mindray Medical International Announces First Quarter 2008 Results 18
(Date:8/21/2014)... near darkness use a previously unknown process for harvesting ... led by a Penn State University scientist has discovered. ... at improving plant growth, harvesting energy from the Sun, ... Lake Erie and other lakes worldwide. A paper describing ... Express edition of the journal Science ...
(Date:8/21/2014)... Nine researchers from Beth Israel Deaconess Medical Center (BIDMC ... World,s Most Influential Scientific Minds 2014," a comprehensive ... a web resource for science metrics and research performance ... the most influential "are performing and publishing work that ... their science," according to a Thomson Reuters statement. Researchers ...
(Date:8/21/2014)... the journal Carcinogenesis by researchers at the ... protein adenomatous polyposis coli (APC) in suppressing colorectal cancer ... U.S. , Lead author Kristi Neufeld, associate professor in ... Cancer Biology program at the KU Cancer Center, has ... understand the various activities of APC, a protein whose ...
Breaking Biology News(10 mins):Hot-spring bacteria reveal ability to use far-red light for photosynthesis 2Hot-spring bacteria reveal ability to use far-red light for photosynthesis 3BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3
... This release is available in Spanish ... ideal for small gardens have been released by Agricultural ... are the latest cultivars released by ARS geneticist Sandy ... Plants Research Unit,s worksite in McMinnville, Tenn. The arboretum ...
... Landry,s Restaurants, Inc. (NYSE: LNY ) ("Landry,s" or ... Special Committee, made up of outside non-employee directors, and attorneys ... , Tilman J. Fertitta has reached a tentative ... claim and certain other claims in connection with Mr. Fertitta,s ...
... 27 DSW Inc. (NYSE: DSW ), a leading branded footwear ... through the first twelve weeks of fiscal 2010 ended April 24, 2010 . ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050629/CLW021LOGO ) , ... As a result, the Company now estimates annual comparable store ...
Cached Biology News:New hydrangea cultivars for landscape gardens 2Landry's Restaurants, Inc. Announces Status of Acquisition by Tilman J. Fertitta and Tentative Partial Settlement of Delaware Lawsuit 2Landry's Restaurants, Inc. Announces Status of Acquisition by Tilman J. Fertitta and Tentative Partial Settlement of Delaware Lawsuit 3Landry's Restaurants, Inc. Announces Status of Acquisition by Tilman J. Fertitta and Tentative Partial Settlement of Delaware Lawsuit 4DSW Inc. Raises Fiscal 2010 Annual Earnings Outlook 2DSW Inc. Raises Fiscal 2010 Annual Earnings Outlook 3
... INTERFERin is a new-generation siRNA transfection ... efficiency at 1 nM siRNA in a ... with excellent cell viability. Using low siRNA ... effects observed when transfecting siRNA at higher ...
... and Tissue Staining Kits are intended for ... of histological and cytological specimens. These kits ... manufactured by either R&D Systems or by ... the formation of the Avidin-Biotin Complex (ABC) ...
... Cellular uptake of long double stranded RNA ... interference in a diverse group of organisms ... RNA interference leads to the inhibition of ... of the target messenger RNA (mRNA). Attempts ...
... is an easy-to-use siRNA transfection reagent that ... genes in a variety of cell lines. ... an optimized, straightforward protocol. High levels of ... following transfection of 20 to 100 nM ...
Biology Products: